Ptc Therapeutics (PTCT) Other Operating Expenses (2012 - 2026)
Ptc Therapeutics (PTCT) posted quarterly Other Operating Expenses of $31.8 million for Q2 2026, down 21.64% quarter-over-quarter from $40.5 million in Q1 2026.
Ptc Therapeutics (PTCT) Other Operating Expenses (2012 - 2026) Analysis & Trends
Ptc Therapeutics' Other Operating Expenses history runs 12 years deep, the most recent figure standing at $31.8 million for Q2 2026.
- In Q2 2026, Other Operating Expenses changed N/A year-over-year to $31.8 million; the TTM figure through Jun 2026 stood at $72.3 million (up 603.63% YoY), while the FY2025 annual figure was $800000.0, down 82.12% from the prior year.
- Other Operating Expenses for Q2 2026 stood at $31.8 million, down from $40.5 million in the prior quarter.
- The five-year high for Other Operating Expenses was $128.9 million in Q2 2023, with the low at -$6.3 million in Q4 2022.
- The 5-year median for Other Operating Expenses is $2.7 million (2023), against an average of $15.4 million.
- Peak annual rise in Other Operating Expenses reached 11800.0% in 2022, while the deepest fall reached 152.07% in 2022.
- Ptc Therapeutics' Other Operating Expenses stood at -$6.3 million in 2022, then surged by 142.86% to $2.7 million in 2023, then jumped by 276.85% to $10.2 million in 2024, then sank by 92.14% to $800000.0 in 2025, then jumped by 3870.25% to $31.8 million in 2026.
- Business Quant data shows PTCT's Other Operating Expenses at $31.8 million in Q2 2026, $40.5 million in Q1 2026, and $800000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Ptc Therapeutics | 5.97 Bn | 3.75 Bn | 340.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 31.76 Mn |
| Mar 31, 2026 | 40.54 Mn |
| Mar 31, 2025 | 800,000.00 |
| Dec 31, 2024 | 10.18 Mn |
| Sep 30, 2024 | -700,000.00 |
| Jun 30, 2024 | -5.10 Mn |
| Mar 31, 2024 | 100,000.00 |
| Dec 31, 2023 | 2.70 Mn |
| Sep 30, 2023 | -1.50 Mn |
| Jun 30, 2023 | 128.90 Mn |
| Mar 31, 2023 | -2.40 Mn |
| Dec 31, 2022 | -6.30 Mn |
| Sep 30, 2022 | 5.30 Mn |
| Jun 30, 2022 | 15.20 Mn |
| Mar 31, 2022 | 11.70 Mn |
| Dec 31, 2021 | 12.10 Mn |
| Sep 30, 2021 | -10.80 Mn |
| Jun 30, 2021 | -700,000.00 |
| Mar 31, 2021 | -100,000.00 |
| Dec 31, 2020 | -6.30 Mn |